Faster approvals for care through prior authorization lose much of their meaning when the payments experience that follows remains slow and unpredictable. With the CMS Interoperability & Prior Authorization Rule
A trailblazer in the nascent male contraceptive market picked up nearly $100 million in funding this week. Contraline closed a $92.5 million Series B financing round on Tuesday, bringing its
Every day, about 6,000 women in the U.S. reach menopause, yet there’s very little funding for research on the condition. That’s what Winona, a telehealth company focused on menopause, hopes
Targeted therapies are bringing new treatment options for a wide range of cancers, but drug resistance still looms for these medicines, including antibody drug conjugates (ADCs), one of the most
About half of adults in the U.S. say it’s difficult to afford healthcare, leading to many putting off care, according to KFF. That’s why a new grassroots campaign aims to
The Trump administration’s turbulent healthcare stewardship claimed another scalp with the departure of the 27th FDA Commissioner Dr. Marty Makary last month after 13 months in the role. He left
Peterson Philanthropies on Tuesday launched Peterson Health Analytics, a public-benefit analytics company for employers, backed by a $50 million commitment. Peterson Philanthropies is a network of nonprofit organizations focused on
The operational structure of the FDA around centers, each governing a particular regulatory or scientific area, dates back more than 40 years. It remains intact for now, but Rick Pazdur,
We continue to see enormous technological and scientific progress in the area of drug discovery, with the promise of AI to upend traditional models and approaches becoming more fully realized
On Tuesday, a startup challenging the traditional real-world data industry announced the close of its Series A funding round. New York-based Novellia raised $18 million, bringing its total funding amount
